世界の心的外傷後ストレス障害（PTSD）治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4715
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、心的外傷後ストレス障害（PTSD）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗うつ薬、抗不安薬）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・心的外傷後ストレス障害（PTSD）治療薬の市場動向
・企業の競争状況、市場シェア
・心的外傷後ストレス障害（PTSD）治療薬の種類別市場規模（抗うつ薬、抗不安薬）
・心的外傷後ストレス障害（PTSD）治療薬の用途別市場規模（病院、薬局、その他）
・心的外傷後ストレス障害（PTSD）治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・心的外傷後ストレス障害（PTSD）治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・心的外傷後ストレス障害（PTSD）治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・心的外傷後ストレス障害（PTSD）治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・心的外傷後ストレス障害（PTSD）治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（GlaxoSmithKline、Pfizer、Eli Lilly、H. Lundbeck）
・結論

Post-Traumatic Stress Disorder (PTSD) therapeutics include drugs that are used in the treatment of PTSD.
The rising prevalence of PTSD to be one of the primary growth factors for the post-traumatic stress disorder (PTSD) therapeutics market.

Market Analysis and Insights: Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market
The global Post-Traumatic Stress Disorder (PTSD) Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Post-Traumatic Stress Disorder (PTSD) Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Post-Traumatic Stress Disorder (PTSD) Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Post-Traumatic Stress Disorder (PTSD) Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Post-Traumatic Stress Disorder (PTSD) Therapeutics market.

Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Scope and Market Size
Post-Traumatic Stress Disorder (PTSD) Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Post-Traumatic Stress Disorder (PTSD) Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Antidepressants
Anxiolytics

Segment by Application
Hospital
Pharmacy
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline
Pfizer
Eli Lilly

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antidepressants
1.2.3 Anxiolytics
1.3 Market by Application
1.3.1 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Perspective (2016-2027)
2.2 Post-Traumatic Stress Disorder (PTSD) Therapeutics Growth Trends by Regions
2.2.1 Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Post-Traumatic Stress Disorder (PTSD) Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Post-Traumatic Stress Disorder (PTSD) Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Post-Traumatic Stress Disorder (PTSD) Therapeutics Industry Dynamic
2.3.1 Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Trends
2.3.2 Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Drivers
2.3.3 Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Challenges
2.3.4 Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Post-Traumatic Stress Disorder (PTSD) Therapeutics Players by Revenue
3.1.1 Global Top Post-Traumatic Stress Disorder (PTSD) Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue
3.4 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Concentration Ratio
3.4.1 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue in 2020
3.5 Post-Traumatic Stress Disorder (PTSD) Therapeutics Key Players Head office and Area Served
3.6 Key Players Post-Traumatic Stress Disorder (PTSD) Therapeutics Product Solution and Service
3.7 Date of Enter into Post-Traumatic Stress Disorder (PTSD) Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Post-Traumatic Stress Disorder (PTSD) Therapeutics Breakdown Data by Type
4.1 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Forecasted Market Size by Type (2022-2027)

5 Post-Traumatic Stress Disorder (PTSD) Therapeutics Breakdown Data by Application
5.1 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2016-2027)
6.2 North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type
6.2.1 North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2016-2027)
6.3 North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application
6.3.1 North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2016-2027)
6.4 North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country
6.4.1 North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2016-2027)
7.2 Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type
7.2.1 Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2016-2027)
7.3 Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application
7.3.1 Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2016-2027)
7.4 Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country
7.4.1 Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type
8.2.1 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application
8.3.1 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Region
8.4.1 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2016-2027)
9.2 Latin America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type
9.2.1 Latin America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application
9.3.1 Latin America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country
9.4.1 Latin America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type
10.2.1 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application
10.3.1 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country
10.4.1 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Post-Traumatic Stress Disorder (PTSD) Therapeutics Introduction
11.1.4 GlaxoSmithKline Revenue in Post-Traumatic Stress Disorder (PTSD) Therapeutics Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Post-Traumatic Stress Disorder (PTSD) Therapeutics Introduction
11.2.4 Pfizer Revenue in Post-Traumatic Stress Disorder (PTSD) Therapeutics Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Post-Traumatic Stress Disorder (PTSD) Therapeutics Introduction
11.3.4 Eli Lilly Revenue in Post-Traumatic Stress Disorder (PTSD) Therapeutics Business (2016-2021)
11.3.5 Eli Lilly Recent Development
11.4 H. Lundbeck
11.4.1 H. Lundbeck Company Details
11.4.2 H. Lundbeck Business Overview
11.4.3 H. Lundbeck Post-Traumatic Stress Disorder (PTSD) Therapeutics Introduction
11.4.4 H. Lundbeck Revenue in Post-Traumatic Stress Disorder (PTSD) Therapeutics Business (2016-2021)
11.4.5 H. Lundbeck Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antidepressants
Table 3. Key Players of Anxiolytics
Table 4. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Regions (2022-2027)
Table 10. Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Trends
Table 11. Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Drivers
Table 12. Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Challenges
Table 13. Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Restraints
Table 14. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Post-Traumatic Stress Disorder (PTSD) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Post-Traumatic Stress Disorder (PTSD) Therapeutics as of 2020)
Table 17. Ranking of Global Top Post-Traumatic Stress Disorder (PTSD) Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Post-Traumatic Stress Disorder (PTSD) Therapeutics Product Solution and Service
Table 21. Date of Enter into Post-Traumatic Stress Disorder (PTSD) Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. GlaxoSmithKline Company Details
Table 62. GlaxoSmithKline Business Overview
Table 63. GlaxoSmithKline Post-Traumatic Stress Disorder (PTSD) Therapeutics Product
Table 64. GlaxoSmithKline Revenue in Post-Traumatic Stress Disorder (PTSD) Therapeutics Business (2016-2021) & (US$ Million)
Table 65. GlaxoSmithKline Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Post-Traumatic Stress Disorder (PTSD) Therapeutics Product
Table 69. Pfizer Revenue in Post-Traumatic Stress Disorder (PTSD) Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Eli Lilly Company Details
Table 72. Eli Lilly Business Overview
Table 73. Eli Lilly Post-Traumatic Stress Disorder (PTSD) Therapeutics Product
Table 74. Eli Lilly Revenue in Post-Traumatic Stress Disorder (PTSD) Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Eli Lilly Recent Development
Table 76. H. Lundbeck Company Details
Table 77. H. Lundbeck Business Overview
Table 78. H. Lundbeck Post-Traumatic Stress Disorder (PTSD) Therapeutics Product
Table 79. H. Lundbeck Revenue in Post-Traumatic Stress Disorder (PTSD) Therapeutics Business (2016-2021) & (US$ Million)
Table 80. H. Lundbeck Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Antidepressants Features
Figure 3. Anxiolytics Features
Figure 4. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Pharmacy Case Studies
Figure 7. Other Case Studies
Figure 8. Post-Traumatic Stress Disorder (PTSD) Therapeutics Report Years Considered
Figure 9. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Players in 2020
Figure 14. Global Top Post-Traumatic Stress Disorder (PTSD) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Post-Traumatic Stress Disorder (PTSD) Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue in 2020
Figure 16. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Type (2016-2027)
Figure 20. North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Application (2016-2027)
Figure 21. North America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Country (2016-2027)
Figure 22. United States Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Region (2016-2027)
Figure 38. China Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. GlaxoSmithKline Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Therapeutics Business (2016-2021)
Figure 58. Pfizer Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Therapeutics Business (2016-2021)
Figure 59. Eli Lilly Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Therapeutics Business (2016-2021)
Figure 60. H. Lundbeck Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Therapeutics Business (2016-2021)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

Global Post-Traumatic Stress Disorder (PTSD) Market Size, Status and Forecast 2021-2027
QYR2104Z4714 2021年4月 132Pages
QYResearch社発行の本調査資料では、心的外傷後ストレス障害（PTSD）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（認知療法、暴露療法、眼球運動脱感作＆再処理（EMDR）、抗うつ薬、抗不安薬、プラゾシン）、用途別市場規模（子供、大人）...

世界の心的外傷後ストレス障害（PTSD）市場規模・現状・予測（2021年-2027年）

世界の全般性不安障害治療市場規模・現状・予測（2021年-2027年）

Global General Anxiety Disorder Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z2524 2021年4月 92Pages
QYResearch社発行の本調査資料では、全般性不安障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（イトリグルミド、テダチオキセチン、EDG-004、その他）、用途別市場規模（クリニック、病院、その他）、主要地域別市場規模（北米、アメ...

世界の精神障害治療市場規模・現状・予測（2021年-2027年）

Global Mental Disorder Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3703 2021年4月 94Pages
QYResearch社発行の本調査資料では、精神障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、自助療法）、用途別市場規模（うつ病、双極性障害、統合失調症、認知症、心的外傷後ストレス障害、その他）、主要地域別市場規模（北米、アメ...

世界の自閉症スペクトラム障害（ASD）診断・治療市場規模・現状・予測（2021年-2027年）

Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z0512 2021年4月 95Pages
QYResearch社発行の本調査資料では、自閉症スペクトラム障害（ASD）診断・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（自閉症、アスペルガー症候群、小児期崩壊性障害、その他）、用途別市場規模（子供・十代、成人）、主要地域別市場規模...

世界の睡眠障害治療薬市場規模・現状・予測（2021年-2027年）

Global Sleep Disorder Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z5284 2021年4月 94Pages
QYResearch社発行の本調査資料では、睡眠障害治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（不眠症、過度睡眠、睡眠障害）、用途別市場規模（病院薬局、オンライン薬局、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア...

世界の閉経後膣萎縮（PVA）治療薬市場規模・現状・予測（2021年-2027年）

Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z4709 2021年4月 93Pages
QYResearch社発行の本調査資料では、閉経後膣萎縮（PVA）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中...

世界の骨髄異形成症候群（MDS）治療薬市場規模・現状・予測（2021年-2027年）

Global Myelodysplastic Syndrome (MDS) Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z3993 2021年4月 99Pages
QYResearch社発行の本調査資料では、骨髄異形成症候群（MDS）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アザシチジン、レナリドマイド、デシタビン、デフェラシロクス、その他）、用途別市場規模（入院患者、外来患者）、主要地域別市...

世界のフォンウィルブランド病（VWD）治療薬市場規模・現状・予測（2021年-2027年）

Global Von Willebrand Disease (VWD) Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z5967 2021年4月 96Pages
QYResearch社発行の本調査資料では、フォンウィルブランド病（VWD）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（デスモプレシン、血栓安定化薬、線維素溶解阻害剤、補充療法、その他）、用途別市場規模（病院薬局、小売薬局、オンライン...

世界の静脈血栓塞栓症（VTE）治療薬市場規模・現状・予測（2021年-2027年）

Global Venous thromboembolism(VTE)Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z5897 2021年4月 98Pages
QYResearch社発行の本調査資料では、静脈血栓塞栓症（VTE）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（深部静脈血栓症（DVT）、肺塞栓症（PE）、その他）、用途別市場規模（病院、外来手術センター、研究所、その他）、主要地域別...

世界の心的外傷後ストレス障害（PTSD）市場規模・現状・予測（2021年-2027年） Post-traumatic stress disorder (PTSD) is a delayed and persistent mental disorder that occurs when an individual experiences, witnesses, or encounters one or more actual deaths involving himself or others, or is threatened with death, or is severely injured, or whose physical integrity is threatened…
世界の心的外傷後ストレス障害（PTSD）市場規模・現状・予測（2021年-2027年） Post-traumatic stress disorder (PTSD) is a delayed and persistent mental disorder that occurs when an individual experiences, witnesses, or encounters one or more actual deaths involving himself or others, or is threatened with death, or is severely injured, or whose physical integrity is threatened…
世界の外傷性脳損傷治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Traumatic Brain Injury Therapeutics Market The global Traumatic Brain Injury Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and hig…
世界の外傷性脳損傷治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Traumatic Brain Injury Therapeutics Market The global Traumatic Brain Injury Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and hig…
世界の外傷性脳損傷治療市場規模・現状・予測（2021年-2027年） Traumatic brain injury usually results from a violent blow or jolt to the head or body. Market Analysis and Insights: Global Traumatic Brain Injuries Treatment Market The global Traumatic Brain Injuries Treatment market size is projected to reach US$ 2584.4 million by 2026, from US$ 2112.1 million i…